A calcium antagonist protects against doxorubicin-induced impairment of calcium handling in neonatal in neonatal rat cardiac myocytes

Japanese Circulation Journal

Volumn 63, Issue 2, 1999, Pages 123-129

  Maeda, Atsuyoshi ^a   Honda, Masaaki ^a   Kuramochi, Takehiko ^a   Takabatake, Toshikazu ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Benidipine; Calcium antagonist; Calcium transients; Doxorubicin; Neonatal rat heart

Indexed keywords

BENIDIPINE; CALCIUM ANTAGONIST; CALCIUM ION; DOXORUBICIN; ISOPRENALINE;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CARDIOTOXICITY; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFICACY; HEART CELL CULTURE; HEART PROTECTION; NEWBORN; NONHUMAN; RAT;

ANIMALS; ANIMALS, NEWBORN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CARDIOMYOPATHIES; CELLS, CULTURED; DIHYDROPYRIDINES; DOXORUBICIN; HEART; ION TRANSPORT; ISOPROTERENOL; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXIDATION-REDUCTION; RATS; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, BETA;

EID: 0033001119     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.123     Document Type: Article

References (43)

1. Von Hoff DD, Layard MW, Basa P, Davs HL Jr, Von Hoff AL, Rozencweig M, et al: Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979; 32: 302-314
2. Olson RD, Mushlin PS: Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEBJ 1990; 4: 3076-3086
3. Cortes EP, Gupta M, Chou C, Amin VC, Folkers K: Adriamycin cardiotoxicity: Early detection by systolic time interval and possible prevention by coenzyme Q10. Cancer Treat Rep 1978; 62: 887-889
4. Speyer JL, Green MD, Kramer E, Rey M, Sanger J, Ward C, et al: Protective effect of the bispiperazinedione ICRF-187 against doxorubicin induced cardiac toxicity in women with advanced breast cancer. N Engl J Med 1988; 319: 745-752
5. Boucek RJ Jr, Buck SH, Scott F, Oquist NL, Fleiscer S, Olson RD: Anthracycline-induced tension in permeabilized cardiac fibers: Evidence for the activation of the calcium release channel of sarcoplasmic reticulum. J Mol Cell Cardiol 1993; 25: 249-259
6. Holmberg SRM, Williams AJ: Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum. Circ Res 1990; 67: 272-283
7. Ondrias K, Borgatta L, Kim DH, Ehrlich BE: Biphasic effects of doxorubicin on the calcium release channel from sarcoplasmic reticulum of cardiac muscle. Circ Res 1990; 67: 1167-1174
8. Dodd DA, Atkinson JB, Olson RD, Buck S, Cusack BJ, Fleischer S, et al: Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of sarcoplasmic reticulum in a chronic rabbit model. J Clin Invest 1993; 91: 1697-1705
9. Wang Y-X, Korth M: Effects of doxorubicin on excitation-contraction coupling in guinea pig ventricular myocardium. Circ Res 1995; 76: 645-653
10. 2+ exchange of dog heart sarcolemmal vesicles. FEBS Lett 1981; 130: 184-186
11. Olson RD, Mushlin PS, Brenner DE, Fleischer S, Cusack BJ, Chang BK, et al: Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. Proc Natl Acad Sci USA 1988; 85: 3585-3589
12. Slater LM, Murray SL, Wetzel MW, Wisdom RM, Duvall EM: Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma. J Clin Invest 1982; 70: 1131-1134
13. Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y: Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res 1983; 43: 2905-2910
14. Rogan AM, Hamilton TC, Young RC: Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science 1984; 224: 994-996
15. Klugman S, Bartoli-Klugman F, Decorti G, Gori D, Silvestri F, Camerini T: Adriamycin experimental cardiomyopathy in Swiss mice: Different effects of two calcium antagonistic drugs on ADM-induced cardiomyopathy. Pharmacol Res Commun 1981; 13: 769-776
16. Rabkin SW, Otten M, Polimeni PI: Increased mortality with cardiotoxic doses of adriamycin after verapamil pretreatment despite prevention of myocardial calcium accumulation. Can J Physiol Pharmacol 1983; 61: 1050-1056
17. Stephens LC, Wang Y-M, Schultheiss, TE, Jardine JH: Enhanced cardiotoxicity in rabbits treated with verapamil and adriamycin. Oncology 1987; 18: 303-306
18. Sridhar R, Dwivedi C, Anderson J, Baker PB, Sharma HM, Desai P, et al: Effects of verapamil on the acute toxicity of doxorubicin in vivo. J Natl Cancer Inst 1991; 84: 1653-1660
19. Engineer FN, Sridhar R: Attenuation of daunorubicin-augmented microsomal lipid peroxidation and oxygen consumption by calcium channel antagonists. Biochem Biophys Res Commun 1991; 179: 1101-1106
20. Goncalves T, Carvalho AP, Oliveira CR: Antioxidant effect of calcium antagonists on microsomal membranes isolated from different brain areas. Eur J Pharmacol 1991; 204: 315-322
21. 2+ channel blocker and antioxidant, reduces neuronal ischemic injuries. Eur J Pharmacol 1994; 257: 203-210
22. Karasawa A, Kubo K: Protection by benidipine hydrochloride (KW-3049), a calcium antagonist, of ischemic kidney in rats via inhibitions of Ca-overload, ATP-decline and lipid peroxidation. Jpn J Pharmacol 1990; 52: 553-562
23. Van Amsterdam FTM, Antonella R, Maiorino M, Ratti E, Ursini F: Lacidipine: A dihydropyridine calcium antagonist with antioxidant activity. Free Radic Biol Med 1992; 12: 183-187
24. Honda M, Morioka S, Yamada S, Ohoka M, Tanabe K, Matsuno Y, et al: Study of cardiac hypertrophy: Humoral factors that stimulate protein metabolism of cultured rat heart cells. Jpn Circ J 1989; 53: 795-806
25. Akimoto H, Bruno NA, Slate DL, Billingham ME, Torti SV, Torti FM: Effect of verapamil on doxorubicin cardiotoxicity: altered muscle gene expression in cultured neonatal rat cardiac myocytes. Cancer Res 1993; 53: 4658-4564
26. Steinberg SF, Robinson RB, Lieberman HB, Stem DM, Rosen MR: Thrombin modulates phosphoinositide metabolism, cytosolic calcium, and impulse initiation in the heart. Circ Res 1991; 68: 1216-1229
27. Kuramochi T, Honda M, Tanaka K, Mansoor AM, Enomoto K, Hashimoto M, et al: Contrasting effects of angiotensin converting enzyme inhibitor and a calcium antagonist on calcium transients in isolated rat cardiac myocytes. Cadiovasc Res 1994; 28: 1407-1413
28. Kuramochi T, Honda M, Tanaka K, Enomoto K, Hashimoto M, Morioka S: Calcium transients in single myocytes and membranous ultrastructures during the development of cardiac hypertrophy and heart failure in rats. Clin Exp Pharmacol Physiol 1994; 21: 1009-1018
29. Honda M, Kuramochi T, Ishinaga Y, Kuzuo H, Tanaka K, Morioka S, et al: Contrasting effects of isoproterenol and phosphodiesterase III inhibitor on intracellular calcium transients in cardiac myocytes from failing hearts. Clin Exp Pharmacol Physiol 1994; 21: 1001-1008
30. Maeda A, Honda M, Kuramochi T, Takabatake T: Doxorubicin cardiotoxicity: diastolic cardiac myocyte dysfunction as a result of impaired calcium handling in isolated cardiac myocytes. Jpn Circ J 1998; 62: 505-511
31. Calderone A, de Champlain J, Rouleau JL: Adriamycin-induced changes to the myocardial beta-adrenergic system in the rabbit. J Mol Cell Cardiol 1991; 23: 333-342
32. Nagami K, Yoshikawa T, Suzuki M, Wainai Y, Anzai T, Handa S: Abnormal β-adrenergic transmembrane signaling in rabbit with adriamycin-induced cardiomyopathy. Jpn Circ J 1997; 61: 249-255
33. Uno Y, Minatoguchi S, Imai Y, Koshiji M, Kakami M, Yokoyama H, et al: Modulation of noradrenaline release via activation of presynaptic β-adrenoceptors in rabbits with adriamycin-induced cardiomyopathy. Jpn Circ J 1993; 57: 426-433
34. Jensen RA: Doxorubicin cardiotoxicity: Contractile change after long-term treatment in the rat. J Pharmacol Exp Ther 1986; 236: 197-203
35. Santostasi G, Kutty RK, Krishna G: Increased toxicity of anthracycline antibiotics induced by calcium entry blockers in cultured cardiomyocytes. Toxicol Appl Pharmacol 1991; 108: 140-149
36. Stepien M, Drzewoski J, Zamolski M: Effect of doxorubicin and verapamil on circulatory system in rabbits. Biol Signals 1994; 3: 44-52
37. Olson RD, Boerth RC, Gerber JG, Nies AS: Mechnism of adrimycin cardiotoxicity: evidence for oxidative stress. Life Sci 1981; 29: 1393-1401
38. Satoh N, Nishimura M, Watanabe Y: Electrophysiologic alterations in the rabbit nodal cells induced by membrane lipid peroxidation. Eur J Pharmacol 1995; 292: 233-240
39. Wang Y-Z, Jia X-A, Zhao J-Y, Xu G-L: Effects of selenium deficiency on Ca transport function of sarcoplasmic reticulum and lipid peroxidation in rat myocardium. Biol Trace Elem Res 1993; 36: 159-166
40. 2+-ATPase by peroxynitrite. Free Radic Res 1996; 24: 243-259
41. Hara H, Kato H, Araki T, Onodera H, Kogure K: Involvement of lipid peroxidation and inhibitory mechanisms on ischemic neuronal damage in gerbil hippocampus: Quantitative autoradiographic studies on second messenger and neurotransmitter systems. Neuroscience 1991; 42: 159-169
42. 2 species on the β-receptor-adenylyl cyclase system. Mol Cell Biochem 1992; 110: 41-46
43. Yamamoto M, Gotoh Y, Imaizumi Y, Watanabe M: Mechanisms of long-lasting effects of benidipine on Ca current in guinea-pig ventricular cells. Br J Pharmacol 1990; 100: 669-676